Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

research The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review

52 citations , August 2021 in “Microorganisms”

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

research Cutaneous toxicity as a predictive biomarker for clinical outcome in patients receiving anticancer therapy

32 citations , May 2018 in “Journal of the American Academy of Dermatology”

Skin reactions from cancer treatments might predict how well the treatments work.

research The effects of pro-, pre-, and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials

14 citations , September 2023 in “Frontiers in Nutrition”

Pro-, pre-, and synbiotics may help with PCOS, but more research is needed.

Korean Obesity Surgical Treatment Study: Protocol of a Prospective Multicentre Cohort Study on Obese Patients Undergoing Laparoscopic Sleeve Gastrectomy and Roux-en-Y Gastric Bypass

research Korean OBEsity Surgical Treatment Study (KOBESS): protocol of a prospective multicentre cohort study on obese patients undergoing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass

10 citations , October 2017 in “BMJ Open”

The Korean study confirmed that bariatric surgery is effective for weight loss in Asians.

research Polyamine Oxidase Expression Is Downregulated by 17β-Estradiol via Estrogen Receptor 2 in Human MCF-7 Breast Cancer Cells

8 citations , July 2022 in “International Journal of Molecular Sciences”

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

The Effects of Spinach-Derived Thylakoid Supplementation in Combination with Calorie Restriction on Anthropometric Parameters and Metabolic Profiles in Obese Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

research The effects of spinach-derived thylakoid supplementation in combination with calorie restriction on anthropometric parameters and metabolic profiles in obese women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled clinical trial

3 citations , August 2020 in “Nutrition Journal”

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

research Impact of subclinical hypothyroidism on endocrine features in patients with polycystic ovary syndrome

1 citations , August 2025 in “European journal of medical research”

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

research Are ABO/Rh blood groups A risk factor for polycystic ovary syndrome?

1 citations , September 2023 in “Medicine”

ABO/Rh blood groups are not a risk factor for PCOS.

The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome: A Review

research The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review

1 citations , January 2023 in “Metabolites”

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

research Patient-Reported Outcomes From Phase III Neoadjuvant Systemic Trial Comparing Neoadjuvant Chemotherapy With Neoadjuvant Endocrine Therapy in Pre-Menopausal Patients With Estrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer

1 citations , July 2021 in “Frontiers in Oncology”

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

← Previous page